Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes
Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is belie...
Gespeichert in:
Veröffentlicht in: | Toxicology and applied pharmacology 2008-09, Vol.231 (2), p.235-240 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 240 |
---|---|
container_issue | 2 |
container_start_page | 235 |
container_title | Toxicology and applied pharmacology |
container_volume | 231 |
creator | Shvedova, A.A. Kisin, E.R. Murray, A.R. Kommineni, C. Castranova, V. Fadeel, B. Kagan, V.E. |
description | Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91
phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT. |
doi_str_mv | 10.1016/j.taap.2008.04.018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_563968</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X08001890</els_id><sourcerecordid>19714208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-7fafd40ade518ba8af22560213c81e2b7e7a44710d6a640559d3676ef658a86a3</originalsourceid><addsrcrecordid>eNp9kc-O0zAQxiMEYsvCC3BAlhDckrUT20klLkv5sytVwAEkbtbEnlCX1A62A8s78NA4tCw3TrbGv_k833xF8ZjRilEmL_ZVApiqmtKuoryirLtTrBhdy5I2TXO3WFHKWZlfP58VD2LcU0rXnLP7xRnrRMOlaFbFr2unA0JEQ0Dr-TCPkKx3xA_E4ZyCn3Z2jAScIQb_koPtg482EutI2iEZZ_dl6Xh3-erDFfE31mSsNDhYbdElshHty-2FJAerkeDN5BeR5ImG0Oe_HDif5h7jw-LeAGPER6fzvPj05vXHzVW5ff_2enO5LbXgbSrbAQbDKRgUrOuhg6GuhaQ1a3THsO5bbIHzllEjQXIqxNo0spU4SNFBJ6E5L8qjbvyB09yrKdgDhJ_Kg1Wn0td8QyVks5Zd5p8eeR9TrmubUO-0dw51UjVjPO9VZur5kZqC_zZjTOpgo8ZxBId-joqtW8ZrusjVR1DnLcaAw-0AjKolWbVXS7JqSVZRrnKyuenJSX3uD2j-tZyizMCzEwBRwzgEcNrGW66msmnFHzMvjhzmDX-3GBZD6DQaGxY_xtv_zfEbkkfCXg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19714208</pqid></control><display><type>article</type><title>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shvedova, A.A. ; Kisin, E.R. ; Murray, A.R. ; Kommineni, C. ; Castranova, V. ; Fadeel, B. ; Kagan, V.E.</creator><creatorcontrib>Shvedova, A.A. ; Kisin, E.R. ; Murray, A.R. ; Kommineni, C. ; Castranova, V. ; Fadeel, B. ; Kagan, V.E.</creatorcontrib><description>Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91
phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1016/j.taap.2008.04.018</identifier><identifier>PMID: 18534653</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>60 APPLIED LIFE SCIENCES ; Animals ; APOPTOSIS ; Apoptosis - drug effects ; Biological and medical sciences ; CARBON ; COLLAGEN ; Collagen - drug effects ; Collagen - metabolism ; Cytokines - drug effects ; Cytokines - metabolism ; Drug toxicity and drugs side effects treatment ; FIBROSIS ; Fibrosis - etiology ; Fibrosis - metabolism ; INFLAMMATION ; Inflammation - etiology ; Inflammation - pathology ; INHALATION ; INJURIES ; Lung - drug effects ; Lung - pathology ; Lung disease ; Lung Diseases - etiology ; Lung Diseases - pathology ; LUNGS ; LYMPHOKINES ; MACROPHAGES ; Male ; Medical sciences ; MICE ; Mice, Inbred C57BL ; Miscellaneous (drug allergy, mutagens, teratogens...) ; NADPH Oxidases - genetics ; NADPH Oxidases - metabolism ; Nanoparticles ; NANOTUBES ; Nanotubes, Carbon - toxicity ; NEUTROPHILS ; Neutrophils - drug effects ; Neutrophils - metabolism ; Occupational Exposure - adverse effects ; OXIDASES ; OXIDATION ; Oxidative enzymes ; Pharmacology. Drug treatments ; Pulmonary injury ; TOXICITY ; Transforming Growth Factor beta - drug effects ; Transforming Growth Factor beta - metabolism</subject><ispartof>Toxicology and applied pharmacology, 2008-09, Vol.231 (2), p.235-240</ispartof><rights>2008 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-7fafd40ade518ba8af22560213c81e2b7e7a44710d6a640559d3676ef658a86a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041008X08001890$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20637568$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18534653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/21140946$$D View this record in Osti.gov$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:117627546$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Shvedova, A.A.</creatorcontrib><creatorcontrib>Kisin, E.R.</creatorcontrib><creatorcontrib>Murray, A.R.</creatorcontrib><creatorcontrib>Kommineni, C.</creatorcontrib><creatorcontrib>Castranova, V.</creatorcontrib><creatorcontrib>Fadeel, B.</creatorcontrib><creatorcontrib>Kagan, V.E.</creatorcontrib><title>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91
phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT.</description><subject>60 APPLIED LIFE SCIENCES</subject><subject>Animals</subject><subject>APOPTOSIS</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>CARBON</subject><subject>COLLAGEN</subject><subject>Collagen - drug effects</subject><subject>Collagen - metabolism</subject><subject>Cytokines - drug effects</subject><subject>Cytokines - metabolism</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>FIBROSIS</subject><subject>Fibrosis - etiology</subject><subject>Fibrosis - metabolism</subject><subject>INFLAMMATION</subject><subject>Inflammation - etiology</subject><subject>Inflammation - pathology</subject><subject>INHALATION</subject><subject>INJURIES</subject><subject>Lung - drug effects</subject><subject>Lung - pathology</subject><subject>Lung disease</subject><subject>Lung Diseases - etiology</subject><subject>Lung Diseases - pathology</subject><subject>LUNGS</subject><subject>LYMPHOKINES</subject><subject>MACROPHAGES</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MICE</subject><subject>Mice, Inbred C57BL</subject><subject>Miscellaneous (drug allergy, mutagens, teratogens...)</subject><subject>NADPH Oxidases - genetics</subject><subject>NADPH Oxidases - metabolism</subject><subject>Nanoparticles</subject><subject>NANOTUBES</subject><subject>Nanotubes, Carbon - toxicity</subject><subject>NEUTROPHILS</subject><subject>Neutrophils - drug effects</subject><subject>Neutrophils - metabolism</subject><subject>Occupational Exposure - adverse effects</subject><subject>OXIDASES</subject><subject>OXIDATION</subject><subject>Oxidative enzymes</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary injury</subject><subject>TOXICITY</subject><subject>Transforming Growth Factor beta - drug effects</subject><subject>Transforming Growth Factor beta - metabolism</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc-O0zAQxiMEYsvCC3BAlhDckrUT20klLkv5sytVwAEkbtbEnlCX1A62A8s78NA4tCw3TrbGv_k833xF8ZjRilEmL_ZVApiqmtKuoryirLtTrBhdy5I2TXO3WFHKWZlfP58VD2LcU0rXnLP7xRnrRMOlaFbFr2unA0JEQ0Dr-TCPkKx3xA_E4ZyCn3Z2jAScIQb_koPtg482EutI2iEZZ_dl6Xh3-erDFfE31mSsNDhYbdElshHty-2FJAerkeDN5BeR5ImG0Oe_HDif5h7jw-LeAGPER6fzvPj05vXHzVW5ff_2enO5LbXgbSrbAQbDKRgUrOuhg6GuhaQ1a3THsO5bbIHzllEjQXIqxNo0spU4SNFBJ6E5L8qjbvyB09yrKdgDhJ_Kg1Wn0td8QyVks5Zd5p8eeR9TrmubUO-0dw51UjVjPO9VZur5kZqC_zZjTOpgo8ZxBId-joqtW8ZrusjVR1DnLcaAw-0AjKolWbVXS7JqSVZRrnKyuenJSX3uD2j-tZyizMCzEwBRwzgEcNrGW66msmnFHzMvjhzmDX-3GBZD6DQaGxY_xtv_zfEbkkfCXg</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Shvedova, A.A.</creator><creator>Kisin, E.R.</creator><creator>Murray, A.R.</creator><creator>Kommineni, C.</creator><creator>Castranova, V.</creator><creator>Fadeel, B.</creator><creator>Kagan, V.E.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope><scope>OTOTI</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20080901</creationdate><title>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</title><author>Shvedova, A.A. ; Kisin, E.R. ; Murray, A.R. ; Kommineni, C. ; Castranova, V. ; Fadeel, B. ; Kagan, V.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-7fafd40ade518ba8af22560213c81e2b7e7a44710d6a640559d3676ef658a86a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>60 APPLIED LIFE SCIENCES</topic><topic>Animals</topic><topic>APOPTOSIS</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>CARBON</topic><topic>COLLAGEN</topic><topic>Collagen - drug effects</topic><topic>Collagen - metabolism</topic><topic>Cytokines - drug effects</topic><topic>Cytokines - metabolism</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>FIBROSIS</topic><topic>Fibrosis - etiology</topic><topic>Fibrosis - metabolism</topic><topic>INFLAMMATION</topic><topic>Inflammation - etiology</topic><topic>Inflammation - pathology</topic><topic>INHALATION</topic><topic>INJURIES</topic><topic>Lung - drug effects</topic><topic>Lung - pathology</topic><topic>Lung disease</topic><topic>Lung Diseases - etiology</topic><topic>Lung Diseases - pathology</topic><topic>LUNGS</topic><topic>LYMPHOKINES</topic><topic>MACROPHAGES</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MICE</topic><topic>Mice, Inbred C57BL</topic><topic>Miscellaneous (drug allergy, mutagens, teratogens...)</topic><topic>NADPH Oxidases - genetics</topic><topic>NADPH Oxidases - metabolism</topic><topic>Nanoparticles</topic><topic>NANOTUBES</topic><topic>Nanotubes, Carbon - toxicity</topic><topic>NEUTROPHILS</topic><topic>Neutrophils - drug effects</topic><topic>Neutrophils - metabolism</topic><topic>Occupational Exposure - adverse effects</topic><topic>OXIDASES</topic><topic>OXIDATION</topic><topic>Oxidative enzymes</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary injury</topic><topic>TOXICITY</topic><topic>Transforming Growth Factor beta - drug effects</topic><topic>Transforming Growth Factor beta - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shvedova, A.A.</creatorcontrib><creatorcontrib>Kisin, E.R.</creatorcontrib><creatorcontrib>Murray, A.R.</creatorcontrib><creatorcontrib>Kommineni, C.</creatorcontrib><creatorcontrib>Castranova, V.</creatorcontrib><creatorcontrib>Fadeel, B.</creatorcontrib><creatorcontrib>Kagan, V.E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>OSTI.GOV</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shvedova, A.A.</au><au>Kisin, E.R.</au><au>Murray, A.R.</au><au>Kommineni, C.</au><au>Castranova, V.</au><au>Fadeel, B.</au><au>Kagan, V.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>231</volume><issue>2</issue><spage>235</spage><epage>240</epage><pages>235-240</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>Single-walled carbon nanotubes (SWCNT) have been introduced into a large number of new technologies and consumer products. The combination of their exceptional features with very broad applications raised concerns regarding their potential health effects. The prime target for SWCNT toxicity is believed to be the lung where exposure may occur through inhalation, particularly in occupational settings. Our previous work has demonstrated that SWCNT cause robust inflammatory responses in rodents with very early termination of the acute phase and rapid onset of chronic fibrosis. Timely elimination of polymorphonuclear neutrophils (PMNs) through apoptosis and their subsequent clearance by macrophages is a necessary stage in the resolution of pulmonary inflammation whereby NADPH oxidase contributes to control of apoptotic cell death and clearance of PMNs. Thus, we hypothesized that NADPH oxidase may be an important regulator of the transition from the acute inflammation to the chronic fibrotic stage in response to SWCNT. To experimentally address the hypothesis, we employed NADPH oxidase-deficient mice which lack the gp91
phox subunit of the enzymatic complex. We found that NADPH oxidase null mice responded to SWCNT exposure with a marked accumulation of PMNs and elevated levels of apoptotic cells in the lungs, production of pro-inflammatory cytokines, decreased production of the anti-inflammatory and pro-fibrotic cytokine, TGF-β, and significantly lower levels of collagen deposition, as compared to C57BL/6 control mice. These results demonstrate a role for NADPH oxidase-derived reactive oxygen species in determining course of pulmonary response to SWCNT.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>18534653</pmid><doi>10.1016/j.taap.2008.04.018</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0041-008X |
ispartof | Toxicology and applied pharmacology, 2008-09, Vol.231 (2), p.235-240 |
issn | 0041-008X 1096-0333 |
language | eng |
recordid | cdi_swepub_primary_oai_swepub_ki_se_563968 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | 60 APPLIED LIFE SCIENCES Animals APOPTOSIS Apoptosis - drug effects Biological and medical sciences CARBON COLLAGEN Collagen - drug effects Collagen - metabolism Cytokines - drug effects Cytokines - metabolism Drug toxicity and drugs side effects treatment FIBROSIS Fibrosis - etiology Fibrosis - metabolism INFLAMMATION Inflammation - etiology Inflammation - pathology INHALATION INJURIES Lung - drug effects Lung - pathology Lung disease Lung Diseases - etiology Lung Diseases - pathology LUNGS LYMPHOKINES MACROPHAGES Male Medical sciences MICE Mice, Inbred C57BL Miscellaneous (drug allergy, mutagens, teratogens...) NADPH Oxidases - genetics NADPH Oxidases - metabolism Nanoparticles NANOTUBES Nanotubes, Carbon - toxicity NEUTROPHILS Neutrophils - drug effects Neutrophils - metabolism Occupational Exposure - adverse effects OXIDASES OXIDATION Oxidative enzymes Pharmacology. Drug treatments Pulmonary injury TOXICITY Transforming Growth Factor beta - drug effects Transforming Growth Factor beta - metabolism |
title | Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T00%3A09%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20accumulation%20of%20neutrophils%20and%20decreased%20fibrosis%20in%20the%20lung%20of%20NADPH%20oxidase-deficient%20C57BL/6%20mice%20exposed%20to%20carbon%20nanotubes&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Shvedova,%20A.A.&rft.date=2008-09-01&rft.volume=231&rft.issue=2&rft.spage=235&rft.epage=240&rft.pages=235-240&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1016/j.taap.2008.04.018&rft_dat=%3Cproquest_swepu%3E19714208%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19714208&rft_id=info:pmid/18534653&rft_els_id=S0041008X08001890&rfr_iscdi=true |